Related Experiment Video

Updated: Aug 15, 2026

Human Colonoid Monolayers to Study Interactions Between Pathogens, Commensals, and Host Intestinal Epithelium
07:20

Human Colonoid Monolayers to Study Interactions Between Pathogens, Commensals, and Host Intestinal Epithelium

Published on: April 9, 2019

Distribution of cytochrome P450 2C, 2E1, 3A4, and 3A5 in human colon mucosa

Ina Bergheim1, Christiane Bode, Alexandr Parlesak

  • 1Hohenheim University (140), Dep, Physiology of Nutrition, Stuttgart, Germany. ina.bergheim@freenet.de

BMC Clinical Pharmacology
|October 29, 2005
PubMed
Abstract

Insights

Cytochrome P450 (CYP) enzyme expression in the human colon varies significantly by location. This research investigated CYP2C, CYP2E1, CYP3A4, and CYP3A5 distribution in the ascending, descending, and sigmoid colon.

Area of Science:

  • Pharmacology
  • Gastroenterology
  • Drug Metabolism

Background:

  • The human colon plays a crucial role in defending against orally ingested substances.
  • Limited knowledge exists regarding the distribution and expression of cytochrome P450 (CYP) enzymes within the human colon.

Purpose of the Study:

  • To investigate the expression and protein levels of key CYP enzymes (CYP2C8, CYP2E1, CYP3A4, and CYP3A5) in different regions of the human colon.
  • To understand the variability of these enzymes in the ascending, descending, and sigmoid colon.

Main Methods:

  • Quantitative analysis of mRNA expression using RT-PCR.
  • Determination of protein concentrations via Western blot analysis.
  • Biopsies were collected from ascending, descending, and sigmoid colon segments.

Main Results:

  • Significant interindividual variability observed in gene expression.
  • CYP2C mRNA levels were higher in the ascending colon compared to the sigmoid colon.
  • CYP2E1 and CYP3A5 mRNA levels were lower in the ascending colon versus descending and sigmoid colon.
  • CYP2C8 protein levels were ~73% higher in the sigmoid colon than the descending colon.
  • CYP2E1 protein concentration was ~81% lower in the sigmoid colon compared to the descending colon.

Conclusions:

  • The expression of CYP2C, CYP2E1, and CYP3A5 enzymes demonstrates regional variation within the human colon.
  • These findings highlight the importance of colon location in drug metabolism and xenobiotic defense.

More Related Videos

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures10:44

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

Related Concept Videos

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...